S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Report of the Expert Panel on Awareness and Behavior Change to the Board of Directors, American Heart Association
Richard A. Carleton,Terry L. Bazzarre,John Drake,Andrea Dunn,Edwin B. Fisher,Scott M. Grundy,Laura L. Hayman,Martha N. Hill,Edward Maibach,James O. Prochaska,Tom Schmid,Sidney C. Smith,Mervyn W. Susser,John W. Worden +13 more
TL;DR: The panel spent a substantial amount of time and effort evaluating alternatives and assessing the strengths and risks or limitations of each and presented the recommendations of the Expert Panel to the Board of Directors.
Journal ArticleDOI
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome
TL;DR: Whether fenofibrate modifies the metabolism of nonesterified (free) fatty acids as a component of its triglyceride‐lowering action in male patients with the metabolic syndrome is investigated.
Journal ArticleDOI
Can we dramatically reduce the incidence of coronary heart disease
TL;DR: The possibility that early implementation of a drug-based approach to the prevention of atherosclerosis and atherothrombotic events could dramatically reduce the footprint of this disease is explored.
Journal ArticleDOI
Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients by Lipid and Nonlipid Biomarkers
Benoit J. Arsenault,Philip J. Barter,David A. DeMicco,Weihang Bao,Gregory M. Preston,John C. LaRosa,Scott M. Grundy,Prakash Deedwania,Heiner Greten,Nanette K. Wenger,James Shepherd,David D. Waters,John J.P. Kastelein +12 more
TL;DR: In patients with stable CHD, atorvastatin improved plasma levels of an expanded panel of nonlipid biomarkers and low-density lipoprotein cholesterol, high-density cholesterol, and triglycerides were all predictive of recurrent MCVEs.
Journal ArticleDOI
Three polymorphisms associated with low hepatic lipase activity are common in African Americans
Liangcai Nie,Sijing Niu,Gloria Lena Vega,Luther T. Clark,Aylmer Tang,Scott M. Grundy,Jonathan Cohen +6 more
TL;DR: This finding, together with the previous data on the -514T allele, indicates that at least three different hepatic lipase polymorphisms associated with low hepaticlipase activity are common among African Americans.